(Q42464493)

1 November 2017

title

Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

1 November 2017

main subject

1 reference

1 reference

1 reference

Garcia-Rudaz C

1

1 reference

1 November 2017

Armando I

2

1 reference

1 November 2017

Levin G

3

1 reference

1 November 2017

Escobar ME

4

1 reference

1 November 2017

Barontini M

5

1 reference

1 November 2017

publication date

1 August 1998

1 reference

1 November 2017

published in

Clinical Endocrinology

1 reference

1 November 2017

volume

49

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

221-228

1 reference

Serum steroids and pituitary hormones in female puberty: a partly longitudinal study

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Polycystic ovary syndrome: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

Polycystic-ovary syndrome--what is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

The polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00511.X

10.1046/J.1365-2265.1998.00511.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference